Inhibition of CTHRC-1 by its specific monoclonal antibody attenuates cervical cancer cell metastasis

Inhibition of CTHRC-1 by its specific monoclonal antibody attenuates cervical cancer cell metastasis

Although combination of surgery and chemo-radiotherapy could cure 80–95% of patients with early cervical cancer, there is still no satisfactory therapeutic strategies for locally advanced and metastatic cervical cancer patients. Our previous study has already investigated that CTHRC-1 is highly expr...

Full description

Bibliographic Details
Main Authors: Xiao-xiao Cui, Hong-mei Ding, Fei Gu, Yuan-yuan Lv, Xin Xing, Rong Zhang
Format: Article
Language:English
Published: Elsevier 2019-02-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Cervical cancer
CTHRC-1
Monoclonal antibody drug
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332218358992

Similar Items

Similar Items